The company has begun dosing up to 60,000 volunteers in a study of its vaccine, marking the first big US trial of an inoculation that may work after just one shot.
The company has begun dosing up to 60,000 volunteers in a study of its vaccine, marking the first big US trial of an inoculation that may work after just one shot.